II
Invirsa, Inc.
SEC filingPharmaceuticals · Columbus, OH
Amount raised$2.9Msold at filing
Total offering$2.9M
Investors in the raise14count reported to the SEC
FiledAug 8, 2025first sale Jul 22, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Rachael WingoExecutive Officer
Wayne EmbreeDirector
Tim WillisDirector
Robert ShalwitzExecutive Officer, Director
Faith VoinovichDirector
Executive officers, directors and promoters as listed on the Form D.